Faecal calprotectin effectively excludes inflammatory bowel disease in 789 symptomatic young adults with/without alarm symptoms: a prospective UK primary care cohort study.

2.50
Hdl Handle:
http://hdl.handle.net/11287/620700
Title:
Faecal calprotectin effectively excludes inflammatory bowel disease in 789 symptomatic young adults with/without alarm symptoms: a prospective UK primary care cohort study.
Authors:
Walker, Gareth; Moore, L.; Heerasing, Neel ( 0000-0003-0579-2062 ) ; Hendy, Peter; Perry, Mandy ( 0000-0003-4303-2718 ) ; McDonald, Timothy J. ( 0000-0003-3559-6660 ) ; Debenham, T; Bethune, Rob; Bewshea, Claire M.; Hyde, Chris; Heap, Graham A.; Singh, A.; Calvert, Christopher; Kennedy, Nicholas A. ( 0000-0003-4368-1961 ) ; Goodhand, James Ross ( 0000-0003-3112-376X ) ; Ahmad, Tariq
Abstract:
Primary care faecal calprotectin testing distinguishes inflammatory bowel disease (IBD) from functional gut disorder in young patients presenting with abdominal symptoms; however, previous evaluations have excluded patients with alarm symptoms.
Citation:
Faecal calprotectin effectively excludes inflammatory bowel disease in 789 symptomatic young adults with/without alarm symptoms: a prospective UK primary care cohort study. 2018, 47 (8):1103-1116 Aliment. Pharmacol. Ther.
Publisher:
Wiley
Journal:
Alimentary pharmacology & therapeutics
Issue Date:
Apr-2018
URI:
http://hdl.handle.net/11287/620700
DOI:
10.1111/apt.14563
PubMed ID:
29508423
Additional Links:
http://dx.doi.org/10.1111/apt.14563
Type:
Journal Article
Language:
en
ISSN:
1365-2036
Appears in Collections:
Colorectal Surgery; Gastroenterology; Exeter Clinical Laboratory International (Blood Sciences, Genetics, Cellular Pathology & Microbiology); 2018 RD&E publications

Full metadata record

DC FieldValue Language
dc.contributor.authorWalker, Garethen
dc.contributor.authorMoore, L.en
dc.contributor.authorHeerasing, Neelen
dc.contributor.authorHendy, Peteren
dc.contributor.authorPerry, Mandyen
dc.contributor.authorMcDonald, Timothy J.en
dc.contributor.authorDebenham, Ten
dc.contributor.authorBethune, Roben
dc.contributor.authorBewshea, Claire M.en
dc.contributor.authorHyde, Chrisen
dc.contributor.authorHeap, Graham A.en
dc.contributor.authorSingh, A.en
dc.contributor.authorCalvert, Christopheren
dc.contributor.authorKennedy, Nicholas A.en
dc.contributor.authorGoodhand, James Rossen
dc.contributor.authorAhmad, Tariqen
dc.date.accessioned2018-05-08T10:18:09Z-
dc.date.available2018-05-08T10:18:09Z-
dc.date.issued2018-04-
dc.identifier.citationFaecal calprotectin effectively excludes inflammatory bowel disease in 789 symptomatic young adults with/without alarm symptoms: a prospective UK primary care cohort study. 2018, 47 (8):1103-1116 Aliment. Pharmacol. Ther.en
dc.identifier.issn1365-2036-
dc.identifier.pmid29508423-
dc.identifier.doi10.1111/apt.14563-
dc.identifier.urihttp://hdl.handle.net/11287/620700-
dc.description.abstractPrimary care faecal calprotectin testing distinguishes inflammatory bowel disease (IBD) from functional gut disorder in young patients presenting with abdominal symptoms; however, previous evaluations have excluded patients with alarm symptoms.en
dc.language.isoenen
dc.publisherWileyen
dc.relation.urlhttp://dx.doi.org/10.1111/apt.14563en
dc.rightsArchived with thanks to Alimentary pharmacology & therapeuticsen
dc.subjectWessex Classification Subject Headings::Gastroenterologyen
dc.titleFaecal calprotectin effectively excludes inflammatory bowel disease in 789 symptomatic young adults with/without alarm symptoms: a prospective UK primary care cohort study.en
dc.typeJournal Articleen
dc.identifier.journalAlimentary pharmacology & therapeuticsen
dc.type.versionPublisheden

Related articles on PubMed

All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.